Factors Influencing Insulin Absorption Around Exercise in Type 1 Diabetes

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2020 Nov 16

PMID 33193089

Citations 9

Authors

Jason P Pitt

Olivia M McCarthy

Thomas Hoeg-Jensen

Benjamin M Wellman

Richard M Bracken

Affiliations

Soon will be listed here.

Abstract

International charities and health care organizations advocate regular physical activity for health benefit in people with type 1 diabetes. Clinical expert and international diabetes organizations' position statements support the management of good glycemia during acute physical exercise by adjusting exogenous insulin and/or carbohydrate intake. Yet research has detailed, and patients frequently report, variable blood glucose responses following both the same physical exercise session and insulin to carbohydrate alteration. One important source of this variability is insulin delivery to the circulation. With modern insulin analogs, it is important to understand how different insulins, their delivery methods, and inherent physiological factors, influence the reproducibility of insulin absorption from the injection site into circulation. Furthermore, contrary to the adaptive pancreatic response to exercise in the person without diabetes, the physiological and metabolic shifts with exercise may increase circulating insulin concentrations that may contribute to exercise-related hyperinsulinemia and consequent hypoglycemia. Thus, a furthered understanding of factors underpinning insulin delivery may offer more confidence for healthcare professionals and patients when looking to improve management of glycemia around exercise.

Citing Articles

Metabolic and Hormonal Responses to Isomaltulose Ingestion Before or During Sustained Submaximal Exercise in Adults with Type 1 Diabetes Using Automated Insulin Delivery Systems.

McCarthy O, Christensen M, Tawfik S, Kristensen K, Hartmann B, Holst J Nutrients. 2024; 16(23.

PMID: 39683492 PMC: 11643935. DOI: 10.3390/nu16234098.

Recommendations for recognizing, risk stratifying, treating, and managing children and adolescents with hypoglycemia.

Zucchini S, Tumini S, Scaramuzza A, Bonfanti R, Delvecchio M, Franceschi R Front Endocrinol (Lausanne). 2024; 15:1387537.

PMID: 38894740 PMC: 11183505. DOI: 10.3389/fendo.2024.1387537.

Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges.

Emad-Eldin M, Balata G, Elshorbagy E, Hamed M, Attia M World J Diabetes. 2024; 15(5):828-852.

PMID: 38766443 PMC: 11099362. DOI: 10.4239/wjd.v15.i5.828.

Pharmacokinetics of cancer therapeutics and energy balance: the role of diet intake, energy expenditure, and body composition.

Purcell S, Kok D, Ketterl T, Garcia M, Joffe L, Brown J J Natl Cancer Inst Monogr. 2023; 2023(61):3-11.

PMID: 37139976 PMC: 10157766. DOI: 10.1093/jncimonographs/lgad010.

The Effect of BMI on Pharmacokinetic and Pharmacodynamic Parameters of Insulin Degludec: Results from an Euglycemic Glucose Clamp Study.

Li T, Liu H, Li S, Yu H, Li J, Tan H Clin Pharmacokinet. 2023; 62(3):449-456.

PMID: 36738401 DOI: 10.1007/s40262-022-01207-1.

References

Turner D, Luzio S, Kilduff L, Gray B, Dunseath G, Bain S . Reductions in resistance exercise-induced hyperglycaemic episodes are associated with circulating interleukin-6 in type 1 diabetes. Diabet Med. 2014; 31(8):1009-13. DOI: 10.1111/dme.12462. View

Ronnemaa T, Koivisto V . Combined effect of exercise and ambient temperature on insulin absorption and postprandial glycemia in type I patients. Diabetes Care. 1988; 11(10):769-73. DOI: 10.2337/diacare.11.10.769. View

HAGGENDAL E, Steen B, Svanborg A . Blood flow in subcutaneous fat tissue in patients with diabetes mellitus. Acta Med Scand. 1970; 187(1-2):49-53. DOI: 10.1111/j.0954-6820.1970.tb02905.x. View

Cengiz E, Weinzimer S, Sherr J, Tichy E, Carria L, Cappiello D . Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming. Diabetes Technol Ther. 2013; 16(1):20-5. PMC: 3887414. DOI: 10.1089/dia.2013.0187. View

Peter R, Luzio S, Dunseath G, Miles A, Hare B, Backx K . Effects of exercise on the absorption of insulin glargine in patients with type 1 diabetes. Diabetes Care. 2005; 28(3):560-5. DOI: 10.2337/diacare.28.3.560. View

Lindholm A, Jacobsen L . Clinical pharmacokinetics and pharmacodynamics of insulin aspart. Clin Pharmacokinet. 2001; 40(9):641-59. DOI: 10.2165/00003088-200140090-00002. View

Richter W, Bhansali S, Morris M . Mechanistic determinants of biotherapeutics absorption following SC administration. AAPS J. 2012; 14(3):559-70. PMC: 3385825. DOI: 10.1208/s12248-012-9367-0. View

Porcellati F, Rossetti P, Busciantella N, Marzotti S, Lucidi P, Luzio S . Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study. Diabetes Care. 2007; 30(10):2447-52. DOI: 10.2337/dc07-0002. View

Nasrallah S, Reynolds L . Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?. Clin Med Insights Endocrinol Diabetes. 2012; 5:31-7. PMC: 3411522. DOI: 10.4137/CMED.S9494. View

10.

Leohr J, Dellva M, Coutant D, LaBell E, Heise T, Andersen G . Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study. Clin Pharmacokinet. 2020; 59(12):1601-1610. PMC: 7716902. DOI: 10.1007/s40262-020-00901-2. View

11.

Brems D, Alter L, Beckage M, CHANCE R, DiMarchi R, Green L . Altering the association properties of insulin by amino acid replacement. Protein Eng. 1992; 5(6):527-33. DOI: 10.1093/protein/5.6.527. View

12.

Fernqvist E, Linde B, Ostman J, Gunnarsson R . Effects of physical exercise on insulin absorption in insulin-dependent diabetics. A comparison between human and porcine insulin. Clin Physiol. 1986; 6(6):489-97. DOI: 10.1111/j.1475-097x.1986.tb00782.x. View

13.

Camacho R, Galassetti P, Davis S, Wasserman D . Glucoregulation during and after exercise in health and insulin-dependent diabetes. Exerc Sport Sci Rev. 2005; 33(1):17-23. View

14.

Frid A, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch L . New Insulin Delivery Recommendations. Mayo Clin Proc. 2016; 91(9):1231-55. DOI: 10.1016/j.mayocp.2016.06.010. View

15.

Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B . Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Clin Ther. 2009; 31(5):980-7. DOI: 10.1016/j.clinthera.2009.05.010. View

16.

Danne T, Becker R, Heise T, Bittner C, Frick A, Rave K . Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes. Diabetes Care. 2005; 28(9):2100-5. DOI: 10.2337/diacare.28.9.2100. View

17.

Berger M, Cuppers H, HEGNER H, Jorgens V, Berchtold P . Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care. 1982; 5(2):77-91. DOI: 10.2337/diacare.5.2.77. View

18.

Sohoel A, Plum A, Frokjaer S, Thygesen P . 125I used for labelling of proteins in an absorption model changes the absorption rate of insulin aspart. Int J Pharm. 2006; 330(1-2):114-20. DOI: 10.1016/j.ijpharm.2006.09.004. View

19.

Kemmer F, Berchtold P, Berger M, Starke A, Cuppers H, Gries F . Exercise-induced fall of blood glucose in insulin-treated diabetics unrelated to alteration of insulin mobilization. Diabetes. 1979; 28(12):1131-7. DOI: 10.2337/diab.28.12.1131. View

20.

Koivisto V . Sauna-induced acceleration in insulin absorption from subcutaneous injection site. Br Med J. 1980; 280(6229):1411-3. PMC: 1601709. DOI: 10.1136/bmj.280.6229.1411. View